Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Cervical Cancer

  Free Subscription


1 Am J Public Health
1 Biosci Rep
1 Biotech Histochem
1 BMC Cancer
1 Breast J
1 Cancer Biother Radiopharm
1 Cancer Control
1 Cancer Prev Res (Phila)
1 Cancer Radiother
1 Cancer Sci
1 Cancers (Basel)
1 Clin Epigenetics
1 Clin Transl Radiat Oncol
1 Data Brief
1 Environ Res
2 Eur Rev Med Pharmacol Sci
1 Front Oncol
1 Gan To Kagaku Ryoho
4 Gynecol Oncol
1 Int J Environ Res Public Health
3 Int J Gynecol Cancer
1 J Clin Pathol
1 J Gene Med
1 J Immunotoxicol
1 J Racial Ethn Health Disparities
1 J Radiat Res
1 J Sex Marital Ther
1 JAMA Netw Open
1 Medicine (Baltimore)
1 Mol Biol Rep
2 Mol Med Rep
1 Onco Targets Ther
1 Oncol Lett
1 Oncol Rep
1 Phys Med
1 Phytother Res
2 PLoS One
1 Rep Pract Oncol Radiother
1 Womens Health (Lond)
2 Zhonghua Fu Chan Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Public Health

    Patricia Gabow Comments.
    Am J Public Health. 2020;110:454-455.
    PubMed         Abstract available

    Biosci Rep

  2. MA X, Liu J, Wang H, Jiang Y, et al
    Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatic analysis.
    Biosci Rep. 2020 May 5. pii: 223801. doi: 10.1042/BSR20194365.
    PubMed         Abstract available

    Biotech Histochem

  3. ARTUN FT, Karagoz A
    Antiproliferative and apoptosis inducing effects of the methanolic extract of Centaurea hermannii in human cervical cancer cell line.
    Biotech Histochem. 2020 May 4:1-10. doi: 10.1080/10520295.2020.1751288.
    PubMed         Abstract available

    BMC Cancer

  4. HE X, Liu J, Xiao L, Zhao M, et al
    Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study.
    BMC Cancer. 2020;20:381.
    PubMed         Abstract available

    Breast J

  5. KUSHVAHA S, Mehta S, Rajan F, R S, et al
    All the lumps are primarily not from breast-report of a metastatic breast lump in a cervical cancer survivor.
    Breast J. 2020 May 7. doi: 10.1111/tbj.13869.

    Cancer Biother Radiopharm

  6. LI X, Li Y, Han Y, Dong B, et al
    miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1.
    Cancer Biother Radiopharm. 2020 May 5. doi: 10.1089/cbr.2019.2983.
    PubMed         Abstract available

    Cancer Control

  7. TANTITAMIT T, Khemapech N, Havanond P, Termrungruanglert W, et al
    Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer.
    Cancer Control. 2020;27:1073274820922540.
    PubMed         Abstract available

    Cancer Prev Res (Phila)

  8. GIZAW M, Teka B, Ruddies F, Kassahun K, et al
    Reasons for Not Attending Cervical Cancer Screening and Associated Factors in Rural Ethiopia.
    Cancer Prev Res (Phila). 2020 May 5. pii: 1940-6207.CAPR-19-0485.
    PubMed         Abstract available

    Cancer Radiother

  9. FOURNIER LS, Bats AS, Durdux C
    Diffusion MRI: Technical principles and application to uterine cervical cancer.
    Cancer Radiother. 2020 Apr 28. pii: S1278-3218(20)30072.
    PubMed         Abstract available

    Cancer Sci

  10. ONUKI M, Matsumoto K, Iwata T, Yamamoto K, et al
    HPV genotype contribution to cervical cancer and precancer: implication for screening and vaccination in Japan.
    Cancer Sci. 2020 May 6. doi: 10.1111/cas.14445.
    PubMed         Abstract available

    Cancers (Basel)

  11. NEMEJCOVA K, Kocian R, Kohler C, Jarkovsky J, et al
    Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2).
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

    Clin Epigenetics

  12. DONG L, Zhang L, Hu SY, Feng RM, et al
    Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
    Clin Epigenetics. 2020;12:62.
    PubMed         Abstract available

    Clin Transl Radiat Oncol

  13. CONWAY JL, Felder S, Tang J, Lukovic J, et al
    Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation.
    Clin Transl Radiat Oncol. 2020;23:1-8.
    PubMed         Abstract available

    Data Brief

  14. HUSSAIN E, Mahanta LB, Borah H, Das CR, et al
    Liquid based-cytology Pap smear dataset for automated multi-class diagnosis of pre-cancerous and cervical cancer lesions.
    Data Brief. 2020;30:105589.
    PubMed         Abstract available

    Environ Res

  15. LIU T, Song Y, Chen R, Zheng R, et al
    Solid fuel use for heating and risks of breast and cervical cancer mortality in China.
    Environ Res. 2020;186:109578.
    PubMed         Abstract available

    Eur Rev Med Pharmacol Sci

  16. OU L, Xiang TY, Hao XY, Wang DZ, et al
    Reduced long non-coding RNA PTENP1 contributed to proliferation and invasion via miR-19b/MTUS1 axis in patients with cervical cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:4132-4144.
    PubMed         Abstract available

  17. LIU Y, An Q, Zhao X
    A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
    Eur Rev Med Pharmacol Sci. 2020;24:4123-4131.
    PubMed         Abstract available

    Front Oncol

  18. DONG T, Yang C, Cui B, Zhang T, et al
    Development and Validation of a Deep Learning Radiomics Model Predicting Lymph Node Status in Operable Cervical Cancer.
    Front Oncol. 2020;10:464.
    PubMed         Abstract available

    Gan To Kagaku Ryoho

  19. YABUNO A, Hasegawa K
    [.The Current Status and Future Perspective of Chemotherapy, Targeted Therapy and Immunotherapy for Cervical Cancer].
    Gan To Kagaku Ryoho. 2020;47:242-246.

    Gynecol Oncol

  20. CLARK KT, Trimble CL
    Current status of therapeutic HPV vaccines.
    Gynecol Oncol. 2019 Dec 20. pii: S0090-8258(19)31838.
    PubMed         Abstract available

  21. DILLEY S, Miller KM, Huh WK
    Human papillomavirus vaccination: Ongoing challenges and future directions.
    Gynecol Oncol. 2020;156:498-502.
    PubMed         Abstract available

  22. VARELA CAGETTI L, Zemmour C, Minsat M, Lambaudie E, et al
    Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy.
    Gynecol Oncol. 2019 Dec 18. pii: S0090-8258(19)31785.
    PubMed         Abstract available

  23. WENZEL HHB, Van Kol KGG, Nijman HW, Lemmens VEPP, et al
    Cervical cancer with </=5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?
    Gynecol Oncol. 2020 May 4. pii: S0090-8258(20)31015.
    PubMed         Abstract available

    Int J Environ Res Public Health

  24. MWANRI L, Gesesew H, Lee V, Hiruy K, et al
    Health Literacy Environment of Breast and Cervical Cancer among Black African Women Globally: A Systematic Review Protocol of Mixed Methods.
    Int J Environ Res Public Health. 2020;17.
    PubMed         Abstract available

    Int J Gynecol Cancer

  25. GROHAR D, Vassilakos P, Benkortbi K, Tincho E, et al
    Scaling up community-based cervical cancer screening in Cameroon employing a single visit approach.
    Int J Gynecol Cancer. 2020 May 4. pii: ijgc-2020-001422.

  26. TSAKMAKLIS A, Vehreschild M, Farowski F, Trommer M, et al
    Changes in the cervical microbiota of cervical cancer patients after primary radio-chemotherapy.
    Int J Gynecol Cancer. 2020 May 5. pii: ijgc-2019-000801.
    PubMed         Abstract available

  27. Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 May 4. pii: ijgc-2019-001012.

    J Clin Pathol

  28. MANCUSI DE CARVALHO JP, Salim RC, Carvalho FM, Nogueira Dias Genta ML, et al
    L1 cell adhesion molecule (L1CAM) in stage IB cervical cancer: distinct expression in squamous cell carcinomas and adenocarcinomas.
    J Clin Pathol. 2020 May 4. pii: jclinpath-2020-206500.
    PubMed         Abstract available

    J Gene Med

  29. ZHANG Y, Yu R, Li L
    LINC00641 hinders the progression of cervical cancer by targeting miR-378a-3p/CPEB3.
    J Gene Med. 2020 May 5:e3212. doi: 10.1002/jgm.3212.
    PubMed         Abstract available

    J Immunotoxicol

  30. VITKAUSKAITE A, Urboniene D, Celiesiute J, Jariene K, et al
    Circulating inflammatory markers in cervical cancer patients and healthy controls.
    J Immunotoxicol. 2020;17:105-109.
    PubMed         Abstract available

    J Racial Ethn Health Disparities

  31. SALIHU H, Dongarwar D, Ikedionwu CA, Shelton A, et al
    Racial/Ethnic Disparities in the Burden of HIV/Cervical Cancer Comorbidity and Related In-hospital Mortality in the USA.
    J Racial Ethn Health Disparities. 2020 May 6. pii: 10.1007/s40615-020-00751.
    PubMed         Abstract available

    J Radiat Res

  32. OKONOGI N, Wakatsuki M, Mizuno H, Fukuda S, et al
    Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.
    J Radiat Res. 2020 May 5. pii: 5829024. doi: 10.1093.
    PubMed         Abstract available

    J Sex Marital Ther

  33. ARAYA-CASTRO P, Sacomori C, Diaz-Guerrero P, Gayan P, et al
    Vaginal Dilator and Pelvic Floor Exercises for Vaginal Stenosis, Sexual Health and Quality of Life among Cervical Cancer Patients Treated with Radiation: Clinical Report.
    J Sex Marital Ther. 2020 May 2:1-15. doi: 10.1080/0092623X.2020.1760981.
    PubMed         Abstract available

    JAMA Netw Open

  34. SAKURAGI N, Kato T, Shimada C, Kaneuchi M, et al
    Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.
    JAMA Netw Open. 2020;3:e204307.
    PubMed         Abstract available

    Medicine (Baltimore)

  35. OMOKAWA N, Mabuchi S, Iwai K, Kawahara N, et al
    Skeletal muscle metastasis as a first site of recurrence of cervical cancer: A case report and review of the literature.
    Medicine (Baltimore). 2020;99:e20056.
    PubMed         Abstract available

    Mol Biol Rep

  36. HEMMAT N, Mokhtarzadeh A, Aghazadeh M, Jadidi-Niaragh F, et al
    Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.
    Mol Biol Rep. 2020 May 7. pii: 10.1007/s11033-020-05494.
    PubMed         Abstract available

    Mol Med Rep

  37. CHEN Y, Liu C, Xie B, Chen S, et al
    miR96 exerts an oncogenic role in the progression of cervical cancer by targeting CAV1.
    Mol Med Rep. 2020 Apr 30. doi: 10.3892/mmr.2020.11101.
    PubMed         Abstract available

  38. CHEN P, Zhang W, Chen Y, Zheng X, et al
    Comprehensive analysis of aberrantly expressed long noncoding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer.
    Mol Med Rep. 2020 May 5. doi: 10.3892/mmr.2020.11120.
    PubMed         Abstract available

    Onco Targets Ther

  39. SHEN X, Zhao W, Zhang Y, Liang B, et al
    Long Non-Coding RNA-NEAT1 Promotes Cell Migration and Invasion via Regulating miR-124/NF-kappaB Pathway in Cervical Cancer.
    Onco Targets Ther. 2020;13:3265-3276.
    PubMed         Abstract available

    Oncol Lett

  40. ZHAO Y, Dong X, Hou R
    lncRNA PICART1 alleviates progression of cervical cancer by upregulating TCF21.
    Oncol Lett. 2020;19:3719-3724.
    PubMed         Abstract available

    Oncol Rep

  41. WU G, Long Y, Lu Y, Feng Y, et al
    Kindlin2 suppresses cervical cancer cell migration through AKT/mTORmediated autophagy induction.
    Oncol Rep. 2020 May 4. doi: 10.3892/or.2020.7603.
    PubMed         Abstract available

    Phys Med

  42. MIYASAKA Y, Kadoya N, Ito K, Umezawa R, et al
    Quantitative analysis of intra-fractional variation in CT-based image guided brachytherapy for cervical cancer patients.
    Phys Med. 2020;73:164-172.
    PubMed         Abstract available

    Phytother Res

  43. DASARI S, Bakthavachalam V, Chinnapaka S, Venkatesan R, et al
    Neferine, an alkaloid from lotus seed embryo targets HeLa and SiHa cervical cancer cells via pro-oxidant anticancer mechanism.
    Phytother Res. 2020 May 4. doi: 10.1002/ptr.6687.
    PubMed         Abstract available

    PLoS One

  44. WU Q, Jia M, Chen H, Zhang S, et al
    The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study.
    PLoS One. 2020;15:e0232129.
    PubMed         Abstract available

  45. DUAN L, Du H, Wang C, Huang X, et al
    The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples.
    PLoS One. 2020;15:e0232107.
    PubMed         Abstract available

    Rep Pract Oncol Radiother

  46. JODDA A, Piotrowski T, Kruszyna-Mochalska M, Malicki J, et al
    Impact of different optimization strategies on the compatibility between planned and delivered doses during radiation therapy of cervical cancer.
    Rep Pract Oncol Radiother. 2020;25:412-421.
    PubMed         Abstract available

    Womens Health (Lond)

  47. CUBIE HA, Campbell C
    Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Womens Health (Lond). 2020;16:1745506520914804.
    PubMed         Abstract available

    Zhonghua Fu Chan Ke Za Zhi

  48. DENG H, Wang JL, Wang ZQ, Li XW, et al
    [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:259-265.
    PubMed         Abstract available

  49. LI PP, Su YH, Zhang MZ
    [Hepatic metastases after cervical cancer surgery: clinical analysis of 13 cases].
    Zhonghua Fu Chan Ke Za Zhi. 2020;55:266-272.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.